Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-005, Research Grants for Preventing Violence and Violence Related Injury (R01); Amended Notice of Meeting, 10366-10367 [2022-03871]

Download as PDF 10366 Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. The reginfo.gov web link is a United States Government website produced by OMB and the General Services Administration (GSA). Under PRA requirements, OMB’s Office of Information and Regulatory Affairs (OIRA) reviews Federal information collections. jspears on DSK121TN23PROD with NOTICES1 FOR FURTHER INFORMATION CONTACT: Ryan Mehm, Attorney, Bureau of Consumer Protection, (202) 326–2918, Federal Trade Commission, 600 Pennsylvania Ave. NW, Washington, DC 20580. SUPPLEMENTARY INFORMATION: Title: Regulation V, Subpart N (12 CFR 1022.130–1022.138). OMB Control Number: 3084–0128. Type of Review: Extension of a currently approved collection. Annual Burden: After halving the updated estimates to split the PRA burden with the CFPB regarding the Rule, the FTC’s burden totals are 192,722 hours, $4,072,801 in associated labor costs, and $6,227,100 in nonlabor/capital costs. Abstract: The FTC shares enforcement authority with the CFPB for subpart N of Regulation V. Subpart N requires nationwide consumer reporting agencies and nationwide consumer specialty reporting agencies to provide to consumers, upon request, one free file disclosure within any 12-month period. Generally, it requires the nationwide consumer reporting agencies, as defined in Section 603(p) of the Fair Credit Reporting Act (FCRA), 15 U.S.C. 1681a(p), to create and operate a centralized source that provides consumers with the ability to request their free annual file disclosures from each of the nationwide consumer reporting agencies through a centralized internet website, toll-free telephone number, and postal address. Subpart N also requires the nationwide consumer reporting agencies to establish a standardized form for internet and mail requests for annual file disclosures, and provides a model standardized form that may be used to comply with that requirement. It additionally requires nationwide specialty consumer reporting agencies, as defined in Section 603(w) of the FCRA, 15 U.S.C. 1681a(w), to establish a streamlined process for consumers to request annual file disclosures. This streamlined process must include a toll-free telephone number for consumers to make such requests. On November 16, 2021, the FTC sought public comment on the VerDate Sep<11>2014 16:46 Feb 23, 2022 Jkt 256001 information collection requirements associated with the Rule. 86 FR 63387. The Commission received no germane comments. Pursuant to the OMB regulations, 5 CFR part 1320, that implement the PRA, 44 U.S.C. 3501 et seq., the FTC is providing this second opportunity for public comment while seeking OMB approval to renew the preexisting clearance for the Rules. Your comment—including your name and your state—will be placed on the public record of this proceeding. Because your comment will be made public, you are solely responsible for making sure that your comment does not include any sensitive personal information, such as anyone’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including in particular competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. for a 2-year period through January 17, 2024. FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., MPH, RS, Designated Federal Officer, Branch Chief, National Center for Environmental Health, CDC, 4770 Buford Highway NE, Atlanta, Georgia 30341, telephone (770) 488– 6774; PAllwood@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Josephine Liu, Assistant General Counsel for Legal Counsel. Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22– 009, Research Grants for Preventing Violence and Violence Related Injury (R01), May 10–11, 2022, 8:30 a.m., EDT– 5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on February 14, 2022, Volume 87, Number 30, page(s) 8252. The meeting is being amended to reflect the correct Notice of Funding Opportunity (NOFO) number and should read as follows: CE22–005, Research Grants for Preventing Violence and Violence Related Injury (R01). The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Official, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone (404) 639–6473, AWilkes@ cdc.gov. [FR Doc. 2022–03914 Filed 2–23–22; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Lead Exposure and Prevention Advisory Committee (LEPAC); Notice of Recharter Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of recharter. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Lead Exposure and Prevention Advisory Committee (LEPAC), Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–03865 Filed 2–23–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22–005, Research Grants for Preventing Violence and Violence Related Injury (R01); Amended Notice of Meeting E:\FR\FM\24FEN1.SGM 24FEN1 Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–03871 Filed 2–23–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Center for Preparedness and Response, (BSC, CPR); Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Center for Preparedness and Response, (BSC, CPR). This is a virtual meeting that is open to the public, limited only by the number of internet conference accesses available, which is 500. Time will be available for public comment. Pre-registration is required by accessing the link in the addresses section. DATES: The meeting will be held on March 24, 2022, from 1:00 p.m. to 3:00 p.m., EDT. ADDRESSES: Zoom Virtual Meeting. If you wish to attend the virtual meeting, please pre-register by accessing the link at: https://cdc.zoomgov.com/webinar/ register/WN_M20Tm8MUTbihUhvg0BcSg. Instructions to access the Zoom virtual meeting will be provided in the link following registration. FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop–H21–6, Atlanta, Georgia 30329–4027, Telephone: (404) 639–7450; Facsimile: (678) 669–1667; Email: DOuisley@ cdc.gov. jspears on DSK121TN23PROD with NOTICES1 SUMMARY: SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 16:46 Feb 23, 2022 Jkt 256001 Purpose: The Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Center for Preparedness and Response (CPR), concerning strategies and goals for the programs and research within CPR, monitoring the overall strategic direction and focus of the CPR Divisions and Offices, and administration and oversight of peer review for CPR scientific programs. For additional information about the Board, please visit: https://www.cdc.gov/cpr/bsc/ index.htm. Matters To Be Considered: The agenda will include: (1) BSC CPR Polio Containment Workgroup (PCWG) Update; and (2) Strategic Capacity Building and Innovation Program Review Working Group Update. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–03869 Filed 2–23–22; 8:45 am] 10367 material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel; (SEP)—RFA–TS–22–001: Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Date: June 17, 2022 Time: 8:30 a.m.–5:30 p.m., EDT. Place: Videoconference. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Mikel Walters, Ph.D., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404)639–0913, MWalters@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–03870 Filed 2–23–22; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10398 #57] Medicaid and Children’s Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the ‘‘generic’’ clearance process. Generally, this is an expedited process by which agencies may obtain OMB’s approval of SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Pages 10366-10367]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03871]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE22-005, Research Grants for Preventing Violence 
and Violence Related Injury (R01); Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE22-009, Research Grants for Preventing Violence and Violence 
Related Injury (R01), May 10-11, 2022, 8:30 a.m., EDT-5:30 p.m., EDT, 
Web Conference, in the original FRN. The meeting was published in the 
Federal Register on February 14, 2022, Volume 87, Number 30, page(s) 
8252.
    The meeting is being amended to reflect the correct Notice of 
Funding Opportunity (NOFO) number and should read as follows: CE22-005, 
Research Grants for Preventing Violence and Violence Related Injury 
(R01).
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Official, National Center for Injury Prevention and Control, 
CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, 
Telephone (404) 639-6473, [email protected].

[[Page 10367]]

    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03871 Filed 2-23-22; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.